Published in Hum Mol Genet on March 12, 2008
Human mitochondrial DNA: roles of inherited and somatic mutations. Nat Rev Genet (2012) 2.59
Consequences of zygote injection and germline transfer of mutant human mitochondrial DNA in mice. Proc Natl Acad Sci U S A (2015) 1.39
Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management. Tex Heart Inst J (2013) 1.30
Therapeutic prospects for mitochondrial disease. Trends Mol Med (2010) 1.17
Is there more to aging than mitochondrial DNA and reactive oxygen species? FEBS J (2009) 1.14
Sequencing strategy for the whole mitochondrial genome resulting in high quality sequences. BMC Genomics (2009) 1.11
Transmission of mitochondrial DNA diseases and ways to prevent them. PLoS Genet (2010) 1.08
Functional consequences of mitochondrial tRNA Trp and tRNA Arg mutations causing combined OXPHOS defects. Eur J Hum Genet (2009) 1.01
Defects in multiple complexes of the respiratory chain are present in ageing human colonic crypts. Exp Gerontol (2010) 0.94
The mtDNA mutator mouse: Dissecting mitochondrial involvement in aging. Aging (Albany NY) (2009) 0.93
Mitochondrial disease in childhood: mtDNA encoded. Neurotherapeutics (2013) 0.93
Genetic Counselling for Maternally Inherited Mitochondrial Disorders. Mol Diagn Ther (2017) 0.92
Mutation in the mitochondrial tRNA(Val) causes mitochondrial encephalopathy, lactic acidosis and stroke-like episodes. Mitochondrion (2011) 0.92
A history of mitochondrial diseases. J Inherit Metab Dis (2010) 0.90
Somatic mitochondrial DNA deletions accumulate to high levels in aging human extraocular muscles. Invest Ophthalmol Vis Sci (2010) 0.88
New mitochondrial DNA mutations in tRNA associated with three severe encephalopamyopathic phenotypes: neonatal, infantile, and childhood onset. Neurogenetics (2012) 0.85
Historical perspective on mitochondrial medicine. Dev Disabil Res Rev (2010) 0.83
Mitochondrial myopathy associated with a novel 5522G>A mutation in the mitochondrial tRNA(Trp) gene. Eur J Hum Genet (2012) 0.82
Molecular pathomechanisms and cell-type-specific disease phenotypes of MELAS caused by mutant mitochondrial tRNA(Trp). Acta Neuropathol Commun (2015) 0.81
Copper and bezafibrate cooperate to rescue cytochrome c oxidase deficiency in cells of patients with SCO2 mutations. Orphanet J Rare Dis (2012) 0.81
Early Onset and Severe Clinical Course Associated with the m.5540G>A Mutation in MT-TW. Mol Genet Metab Rep (2014) 0.81
A novel mitochondrial tRNA Arg mutation resulting in an anticodon swap in a patient with mitochondrial encephalomyopathy. Eur J Hum Genet (2012) 0.76
Mitochondrial disorders: challenges in diagnosis & treatment. Indian J Med Res (2015) 0.75
Mitochondrial disease and endocrine dysfunction. Nat Rev Endocrinol (2016) 0.75
Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem (1987) 59.79
Compilation of tRNA sequences and sequences of tRNA genes. Nucleic Acids Res (1998) 10.74
Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science (1989) 9.71
Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell (1990) 6.80
In vivo labeling and analysis of human mitochondrial translation products. Methods Enzymol (1996) 2.84
Mitochondrial threshold effects. Biochem J (2003) 2.45
Cytochemistry and immunocytochemistry of mitochondria in tissue sections. Methods Enzymol (1996) 2.19
The second to last amino acid in the nascent peptide as a codon context determinant. EMBO J (1994) 1.98
The mitochondrial tRNA(Leu(UUR)) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): genetic, biochemical, and morphological correlations in skeletal muscle. Am J Hum Genet (1992) 1.94
MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNA(Lys) and premature translation termination. Nat Genet (1995) 1.83
Modification defect at anticodon wobble nucleotide of mitochondrial tRNAs(Leu)(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. J Biol Chem (2000) 1.57
Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease. Proc Natl Acad Sci U S A (2005) 1.50
Mitochondrial encephalomyopathies: an update. Neuromuscul Disord (2005) 1.45
A tRNA suppressor mutation in human mitochondria. Nat Genet (1998) 1.27
Copper supplementation restores cytochrome c oxidase activity in cultured cells from patients with SCO2 mutations. Biochem J (2002) 1.17
Mitochondrial DNA depletion and dGK gene mutations. Ann Neurol (2002) 1.17
A mitochondrial tRNA anticodon swap associated with a muscle disease. Nat Genet (1993) 1.15
Mitochondrial codes and evolution. Nature (1983) 1.09
The mitochondrial tRNA(Leu)(UUR)) mutation in MELAS: a model for pathogenesis. Biochim Biophys Acta (1992) 1.08
A disease-associated G5703A mutation in human mitochondrial DNA causes a conformational change and a marked decrease in steady-state levels of mitochondrial tRNA(Asn). Mol Cell Biol (1997) 1.08
Dominance and homozygosity. Am J Med Genet (1997) 1.08
Identification of transfer RNA suppressors in Escherichia coli. III. Ochre suppressors of lysine tRNA. J Mol Biol (1984) 1.03
Mutation screening in patients with isolated cytochrome c oxidase deficiency. Pediatr Res (2003) 1.02
In vitro analysis of mutations causing myoclonus epilepsy with ragged-red fibers in the mitochondrial tRNA(Lys)gene: two genotypes produce similar phenotypes. Mol Cell Biol (1995) 1.02
Effect of a mutation in the anticodon of human mitochondrial tRNAPro on its post-transcriptional modification pattern. Nucleic Acids Res (1998) 0.99
Mitochondrial respiratory-chain diseases. N Engl J Med (2003) 8.68
The kinase domain of mitochondrial PINK1 faces the cytoplasm. Proc Natl Acad Sci U S A (2008) 3.65
MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet (2006) 3.17
Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell (2013) 3.02
Mitochondrial disorders in the nervous system. Annu Rev Neurosci (2008) 2.93
Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet (2012) 2.82
A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am J Hum Genet (2005) 2.73
Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am J Hum Genet (2006) 2.66
Human mitochondrial DNA: roles of inherited and somatic mutations. Nat Rev Genet (2012) 2.59
FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol (2011) 2.36
In vivo correction of COX deficiency by activation of the AMPK/PGC-1α axis. Cell Metab (2011) 2.33
COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest (2011) 2.21
Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus. Nat Genet (2002) 2.20
An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients. Neuromuscul Disord (2007) 2.17
Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann Neurol (2002) 2.14
Rescue of a mitochondrial deficiency causing Leber Hereditary Optic Neuropathy. Ann Neurol (2002) 2.13
Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells. Nat Protoc (2012) 2.12
ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. Am J Hum Genet (2008) 2.04
Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants. Nature (2012) 1.95
Argininosuccinate lyase deficiency: mutational spectrum in Italian patients and identification of a novel ASL pseudogene. Hum Mutat (2007) 1.91
The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells. Cardiovasc Res (2010) 1.89
Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol (2005) 1.77
Heterogeneity of coenzyme Q10 deficiency: patient study and literature review. Arch Neurol (2012) 1.77
Mitochondrial haplogroup N9a confers resistance against type 2 diabetes in Asians. Am J Hum Genet (2007) 1.76
Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. Arthritis Rheum (2006) 1.76
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Invest (2013) 1.74
The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene. Brain (2007) 1.73
Mitochondrial DNA deletions inhibit proteasomal activity and stimulate an autophagic transcript. Free Radic Biol Med (2006) 1.73
The clinical maze of mitochondrial neurology. Nat Rev Neurol (2013) 1.72
A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease. Am J Hum Genet (2009) 1.71
Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage. Proc Natl Acad Sci U S A (2005) 1.68
Missense mutation of the COQ2 gene causes defects of bioenergetics and de novo pyrimidine synthesis. Hum Mol Genet (2007) 1.67
Coenzyme Q deficiency triggers mitochondria degradation by mitophagy. Autophagy (2009) 1.65
LETM1, deleted in Wolf-Hirschhorn syndrome is required for normal mitochondrial morphology and cellular viability. Hum Mol Genet (2007) 1.64
Varying loads of the mitochondrial DNA A3243G mutation in different tissues: implications for diagnosis. Am J Med Genet A (2004) 1.64
Mitochondrial nucleoids maintain genetic autonomy but allow for functional complementation. J Cell Biol (2008) 1.63
Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N Engl J Med (2008) 1.63
A mouse model for Glut-1 haploinsufficiency. Hum Mol Genet (2006) 1.63
Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. J Clin Invest (2003) 1.60
Phospholipid abnormalities in children with Barth syndrome. J Am Coll Cardiol (2003) 1.59
Human NARP mitochondrial mutation metabolism corrected with alpha-ketoglutarate/aspartate: a potential new therapy. Arch Neurol (2009) 1.58
A homoplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited hypertrophic cardiomyopathy. J Am Coll Cardiol (2003) 1.57
Delayed developmental language milestones in children with Duchenne's muscular dystrophy. J Pediatr (2007) 1.55
Severe pulmonary hypertension associated with primary Sjögren's syndrome. Intern Med (2003) 1.55
Novel cell lines derived from adult human ventricular cardiomyocytes. J Mol Cell Cardiol (2005) 1.54
Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights. J Neuropathol Exp Neurol (2005) 1.53
Navajo neurohepatopathy is caused by a mutation in the MPV17 gene. Am J Hum Genet (2006) 1.53
Upregulated function of mitochondria-associated ER membranes in Alzheimer disease. EMBO J (2012) 1.53
Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem (2001) 1.52
Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation. J Immunol (2009) 1.52
Mitochondrial DNA abnormalities and autistic spectrum disorders. J Pediatr (2004) 1.49
The vascular endothelium and human diseases. Int J Biol Sci (2013) 1.49
Resistin is closely related to systemic inflammation in obstructive sleep apnea. Respiration (2008) 1.48
Use of the Faces Pain Scale by left and right hemispheric stroke patients. Pain (2006) 1.47
Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy. Brain (2011) 1.46
Coenzyme Q-responsive Leigh's encephalopathy in two sisters. Ann Neurol (2002) 1.45
Mitochondrial encephalomyopathies: an update. Neuromuscul Disord (2005) 1.45
Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke. Arch Neurol (2004) 1.42
Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J Neurochem (2002) 1.42
Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND). Pediatr Phys Ther (2011) 1.42
Respiratory chain dysfunction and oxidative stress correlate with severity of primary CoQ10 deficiency. FASEB J (2008) 1.41
Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy. Nature (2011) 1.41
X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1. Am J Hum Genet (2008) 1.40
Two direct repeats cause most human mtDNA deletions. Trends Genet (2004) 1.39
Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle. J Mol Med (Berl) (2004) 1.39
Mitochondrial DNA depletion syndrome due to mutations in the RRM2B gene. Neuromuscul Disord (2008) 1.39
N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2012) 1.38
Abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease. J Neurol (2010) 1.38
The D4Z4 macrosatellite repeat acts as a CTCF and A-type lamins-dependent insulator in facio-scapulo-humeral dystrophy. PLoS Genet (2009) 1.37
Reactive oxygen species, oxidative stress, and cell death correlate with level of CoQ10 deficiency. FASEB J (2010) 1.36
Biochemical analysis of respiratory function in cybrid cell lines harbouring mitochondrial DNA mutations. Biochem J (2004) 1.36